187 related articles for article (PubMed ID: 8839618)
1. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis.
Dalakas MC; Sivakumar K
Curr Opin Neurol; 1996 Jun; 9(3):235-9. PubMed ID: 8839618
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
Dalakas MC
Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
[TBL] [Abstract][Full Text] [Related]
3. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
[No Abstract] [Full Text] [Related]
4. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
5. Expression of granulysin in polymyositis and inclusion-body myositis.
Ikezoe K; Ohshima S; Osoegawa M; Tanaka M; Ogawa K; Nagata K; Kira JI
J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1187-90. PubMed ID: 16980658
[TBL] [Abstract][Full Text] [Related]
6. New developments in the role of cytokines and chemokines in inflammatory myopathies.
Lundberg IE; Nyberg P
Curr Opin Rheumatol; 1998 Nov; 10(6):521-9. PubMed ID: 9812212
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
8. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
Murata K; Dalakas MC
Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938
[TBL] [Abstract][Full Text] [Related]
9. Association of inclusion body myositis with T cell large granular lymphocytic leukaemia.
Greenberg SA; Pinkus JL; Amato AA; Kristensen T; Dorfman DM
Brain; 2016 May; 139(Pt 5):1348-60. PubMed ID: 26920676
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory disease.
Curr Opin Neurol; 1996 Jun; 9(3):B65-76. PubMed ID: 8839622
[No Abstract] [Full Text] [Related]
11. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.
De Bleecker JL; Meire VI; Declercq W; Van Aken EH
Neuromuscul Disord; 1999 Jun; 9(4):239-46. PubMed ID: 10399751
[TBL] [Abstract][Full Text] [Related]
13. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory myopathies.
Amato AA; Greenberg SA
Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
[TBL] [Abstract][Full Text] [Related]
15. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
16. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
17. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
18. Polymyositis and dermatomyositis.
Dalakas MC; Hohlfeld R
Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
20. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Gulati S; Handa R
Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
